Skip to main content
PMC home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2001 Aug;51(469):619–624.

A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.

N T Lewin van den Broek 1, M E Numans 1, E Buskens 1, T J Verheij 1, N J de Wit 1, A J Smout 1
PMCID: PMC1314070  PMID: 11510389

Abstract

BACKGROUND: The first step in the management of uncomplicated dyspepsia in primary care often consists of prescribing empirical therapy, but in certain cases prompt endoscopy might be preferred. Any decision is usually based on the patient's symptoms and the presumed underlying pathology that causes these symptoms. AIM: To assess the relationship between symptom subgroups and the effect of management strategies on primary care patients with dyspepsia. DESIGN OF STUDY: Randomised controlled trial. SETTING: All patients presenting successively with a new episode of dyspepsia between January 1995 and November 1997. METHOD: The results of four management strategies in dyspeptic primary care patients were compared and the value of subgrouping within this trial was estimated. Patients were allocated to one of either (a) empirical treatment in which therapy was based on the presented symptoms, or empirical treatment with (b) omeprazole or (c) cisapride regardless of the presented symptoms, or (d) prompt endoscopy followed by the appropriate treatment. Patients were retrospectively classified into the subgroups for each strategy using baseline data. The yield of each strategy was measured by counting the number of strategy failures in the first year. RESULTS: Of the 349 included patients, 326 were analysed. No statistically significant difference could be demonstrated between the strategies or between the symptom subgroups. However, patients in the reflux-like subgroup showed a trend towards a better outcome in all empirical strategies. Ulcer-like dyspepsia seemed to benefit from omeprazole. The non-specific subgroup seemed to benefit from cisapride but also had the highest proportion of strategy failure. Prompt endoscopy did not appear especially useful in any subgroup. CONCLUSION: Although this study has relatively low power, we conclude that the use of symptom subgroups seems to be a sensible approach when choosing empirical therapy in dyspepsia. Patients with reflux-like symptoms seem to have the best prognosis in the first year in every strategy.

Full Text

The Full Text of this article is available as a PDF (87.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agréus L., Engstrand L., Svärdsudd K., Nyrén O., Tibblin G. Helicobacter pylori seropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiologic study. Scand J Gastroenterol. 1995 Aug;30(8):752–757. doi: 10.3109/00365529509096323. [DOI] [PubMed] [Google Scholar]
  2. Bytzer P., Hansen J. M., Havelund T., Malchow-Møller A., Schaffalitzky de Muckadell O. B. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol. 1996 Apr;8(4):359–363. doi: 10.1097/00042737-199604000-00014. [DOI] [PubMed] [Google Scholar]
  3. Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet. 1994 Apr 2;343(8901):811–816. doi: 10.1016/s0140-6736(94)92023-0. [DOI] [PubMed] [Google Scholar]
  4. Bytzer P., Hansen J. M., Schaffalitzky de Muckadell O. B., Malchow-Møller A. Predicting endoscopic diagnosis in the dyspeptic patient. The value of predictive score models. Scand J Gastroenterol. 1997 Feb;32(2):118–125. doi: 10.3109/00365529709000181. [DOI] [PubMed] [Google Scholar]
  5. Festen H. P., Schenk E., Tan G., Snel P., Nelis F. Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group. Am J Gastroenterol. 1999 Apr;94(4):931–936. doi: 10.1111/j.1572-0241.1999.989_l.x. [DOI] [PubMed] [Google Scholar]
  6. Halter F., Miazza B., Brignoli R. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study. Scand J Gastroenterol. 1994 Jul;29(7):618–623. doi: 10.3109/00365529409092482. [DOI] [PubMed] [Google Scholar]
  7. Hansen J. M., Bytzer P., Schaffalitzky De Muckadell O. B. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol. 1998 Aug;33(8):799–805. doi: 10.1080/00365529850171431. [DOI] [PubMed] [Google Scholar]
  8. Heikkinen M., Pikkarainen P., Takala J., Julkunen R. General practitioners' approach to dyspepsia. Survey of consultation frequencies, treatment, and investigations. Scand J Gastroenterol. 1996 Jul;31(7):648–653. doi: 10.3109/00365529609009144. [DOI] [PubMed] [Google Scholar]
  9. Klauser A. G., Schindlbeck N. E., Müller-Lissner S. A. Symptoms in gastro-oesophageal reflux disease. Lancet. 1990 Jan 27;335(8683):205–208. doi: 10.1016/0140-6736(90)90287-f. [DOI] [PubMed] [Google Scholar]
  10. Lewin-van den Broek N. T., Numans M. E., Buskens E., de Wit N. J., Smout A. J., Verheij T. J. Validation and value of an enzyme-linked immunosorbent assay for Helicobacter pylori in primary care. Scand J Gastroenterol. 1999 Apr;34(4):391–395. doi: 10.1080/003655299750026407. [DOI] [PubMed] [Google Scholar]
  11. Lundquist P., Seensalu R., Lindén B., Nilsson L. H., Lindberg G. Symptom criteria do not distinguish between functional and organic dyspepsia. Eur J Surg. 1998 May;164(5):345–352. doi: 10.1080/110241598750004373. [DOI] [PubMed] [Google Scholar]
  12. Malfertheiner P., Mégraud F., O'Morain C., Bell D., Bianchi Porro G., Deltenre M., Forman D., Gasbarrini G., Jaup B., Misiewicz J. J. Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG). Eur J Gastroenterol Hepatol. 1997 Jan;9(1):1–2. doi: 10.1097/00042737-199701000-00002. [DOI] [PubMed] [Google Scholar]
  13. Meineche-Schmidt V., Krag E. Dyspepsia in general practice in Denmark. A 1-year analysis of consulters in general practice. Scand J Prim Health Care. 1998 Dec;16(4):216–221. doi: 10.1080/028134398750002981. [DOI] [PubMed] [Google Scholar]
  14. Moayyedi P., Soo S., Deeks J., Forman D., Mason J., Innes M., Delaney B. Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ. 2000 Sep 16;321(7262):659–664. doi: 10.1136/bmj.321.7262.659. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Numans M. E., Van der Graaf Y., de Wit N. J., Touw-Otten F., de Melker R. A. How much ulcer is ulcer-like? Diagnostic determinants of peptic ulcer in open access gastroscopy. Fam Pract. 1994 Dec;11(4):382–388. doi: 10.1093/fampra/11.4.382. [DOI] [PubMed] [Google Scholar]
  16. Ofman J. J., Rabeneck L. The effectiveness of endoscopy in the management of dyspepsia: a qualitative systematic review. Am J Med. 1999 Mar;106(3):335–346. doi: 10.1016/s0002-9343(99)00016-9. [DOI] [PubMed] [Google Scholar]
  17. Penston J. G., Pounder R. E. A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther. 1996 Feb;10(1):83–89. doi: 10.1111/j.1365-2036.1996.tb00180.x. [DOI] [PubMed] [Google Scholar]
  18. Quartero A. O., de Wit N. J., Lodder A. C., Numans M. E., Smout A. J., Hoes A. W. Disturbed solid-phase gastric emptying in functional dyspepsia: a meta-analysis. Dig Dis Sci. 1998 Sep;43(9):2028–2033. doi: 10.1023/a:1018803129779. [DOI] [PubMed] [Google Scholar]
  19. Rauws E. A., Tytgat G. N. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet. 1990 May 26;335(8700):1233–1235. doi: 10.1016/0140-6736(90)91301-p. [DOI] [PubMed] [Google Scholar]
  20. Schenk B. E., Kuipers E. J., Klinkenberg-Knol E. C., Festen H. P., Jansen E. H., Tuynman H. A., Schrijver M., Dieleman L. A., Meuwissen S. G. Omeprazole as a diagnostic tool in gastroesophageal reflux disease. Am J Gastroenterol. 1997 Nov;92(11):1997–2000. [PubMed] [Google Scholar]
  21. van Pinxteren B., Numans M. E., Bonis P. A., Lau J. Short-term treatment with proton pump inhibitors, H2-receptor antagonists and prokinetics for gastro-oesophageal reflux disease-like symptoms and endoscopy negative reflux disease. Cochrane Database Syst Rev. 2000;(2):CD002095–CD002095. doi: 10.1002/14651858.CD002095. [DOI] [PubMed] [Google Scholar]
  22. van de Wouw B. A., de Boer W. A., Jansz A. R., Staals A. P., Roymans R. T. Serodiagnosis of Helicobacter pylori infection: an evaluation of a commercially available ELISA-IgG. Neth J Med. 1995 Dec;47(6):272–277. doi: 10.1016/0300-2977(95)00104-2. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES